Public data workspaceRead-only tender record
Public tender

DAK-Gesundheit Procurement Tender in Balingen-Frommern

Erfüllungsort: 72336 Balingen - Frommern Vergabestelle: DAK-Gesundheit Angebotsfrist: 20.03.2026 12:00 Veröffentlichungsende: 20.03.2026 12:00

Source ID: DE-BUND-IMPORTE-Ausschreibungen-dtvp-2026-02-314097

Scope overview

Erfüllungsort: 72336 Balingen - Frommern Vergabestelle: DAK-Gesundheit Angebotsfrist: 20.03.2026 12:00 Veröffentlichungsende: 20.03.2026 12:00

Statusopen
CountryGermany
Publish dateFeb 19, 2026
Submission deadlineMar 20, 2026
Estimated value
Notice typetender_notice
Sourcede-bund-ausschreibungen-rss
BuyerDAK-Gesundheit
Buyer websitehttps://www.service.bund.de/
City

Buyer & contacts

Public read-only access
Contact fields are visible publicly. Use the workspace for exports, buyer tracking, and alerts.
Open workspace
Emailredaktion-buergeranfragen@bva.bund.de
OrganizationDAK-Gesundheit

Tags & Signals

DAK-Gesundheitpublic procurementBalingen-Frommerntender submissionoffer deadlineprocurement process

Similar tenders

GermanyOtheropen

DAK-Gesundheit Framework Agreement for Estradiol Dienogest Pharmaceutical Supply

DAK-Gesundheit is establishing a framework agreement for the supply of pharmaceuticals containing the active ingredient Estradiol + Dienogest (ATC G03AB08). The initial contract period runs from March 1, 2026, to February 28, 2028, with an optional 12-month extension. Pharmaceutical companies can join this open enrollment model at any time by submitting required documents via email by specified deadlines. The procedure is not considered a formal public procurement under competition law due to its non-discriminatory, open-access nature.

Published: Jan 19, 2026Deadline: Dec 29, 2028ID: TED-315be9bd-080a-452e-9333-49ff5090f67c
€1
GermanyOtheropen

DAK-Gesundheit Framework Agreement for Ezetimib + Atorvastatin Pharmaceutical Supply

DAK-Gesundheit is establishing a framework agreement for the supply of Ezetimib + Atorvastatin (ATC C10BA05) in 90-count packages, effective from March 1, 2026 to February 28, 2028 with a possible 12-month extension. The model allows pharmaceutical companies to join at any time under equal conditions by submitting required documents via email. This procedure is considered outside standard public procurement rules due to its non-discriminatory open access nature.

Published: Jan 19, 2026Deadline: Dec 29, 2028ID: TED-269d2182-eb90-49ed-8a41-6b8b325ec936
€1
GermanyHealthcare & Medicalopen

Pharmaceutical Framework Agreement for Follitropin Alfa Under German Competition Law

The DAK-Gesundheit is establishing a framework agreement for the pharmaceutical substance Follitropin alfa (ATC G03GA05) that will become effective on February 1, 2026. This procedure operates outside standard public procurement rules due to its non-discriminatory, open-access model for all pharmaceutical companies. Any qualified company may join the agreement at any time during its term under identical conditions by submitting required documentation.

Published: Dec 15, 2025Deadline: Nov 28, 2027ID: TED-b5fe30c4-567f-496e-89a2-56de23057fd7
€1
Unlock actions

Keep reading for free. Pay only when you need workspace actions.

This record stays public. Upgrade only when you want alerts, exports, OCR packs, and autopilot workflows inside the private workspace.

Disclaimer: IndexBox Tenders does not issue, announce, or publish this tender. This information is aggregated from publicly available sources and is provided for informational purposes only. IndexBox Tenders is not affiliated with, endorsed by, or acting on behalf of the tender issuer. Users should verify all information directly with the official tender source before making any decisions or taking any action.